SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Director/PDMR Shareholding

17 Feb 2010 15:15

RNS Number : 3001H
Victrex PLC
17 February 2010
 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes in block capital letters.

 

1. Name of the issuer

Victrex plc

2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii)

(iii) Mr David Hummel and Mr Michael Peacock

(i) Mr Tim Cooper

3. Name of person discharging managerial responsibilities/director

Mr David Hummel

Mr Michael Peacock

Mr Tim Cooper

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

NA

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

As above

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Ordinary shares of 1p each in Victrex plc

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

As above

 

8 State the nature of the transaction

a) An award to Mr Tim Cooper of 13,487 options under the Victrex plc Long Term Incentive plan. The award, which was granted for nil consideration, takes the form of options to acquire ordinary shares for nil consideration, conditional upon the satisfaction of certain targets over a three year performance period.

b) Exercise of share options awarded under the 1999 Victrex plc Long Term Incentive Plan:

Mr David Hummel exercised 47,038 options granted on 6 April 2005 and 37,905 options granted on 15 December 2005 both at a nil exercise price.

Mr Michael Peacock exercised 35,849 options granted on 6 April 2005 and 26,814 options granted on 15 December 2005 both at a nil exercise price.

 c) Sale of shares in order to fund the Directors' tax liabilities arising on the above exercise of options together with the associated dealing costs:

 Mr David Hummel: 43,408 shares

 Mr Michael Peacock: 25,769 shares

9. Number of shares, debentures or financial instruments relating to shares acquired

Mr Tim Cooper: 13,487 options under the Victrex plc 2009 Long Term Incentive Plan

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

NA

11. Number of shares, debentures or financial instruments relating to shares disposed

Mr David Hummel: 43,408 shares

Mr Michael Peacock: 25,769 shares

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 

0.08%

13. Price per share or value of transaction

£8.11

14. Date and place of transaction

15 February 2010: Thornton Cleveleys, UK

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Mr David Hummel: 3,850,475 4.63%

Mr Michael Peacock: 124,487 0.15%

Mr Tim Cooper: 0 NA

 

16. Date issuer informed of transaction

16 February 2010

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

 

17. Date of grant

15 February 2010

18. Period during which or date on which it can be exercised

15 February 2015 - 15 February 2020

19. Total amount paid (if any) for grant of the option

Nil

20. Description of shares or debentures involved (class and number)

Ordinary shares of 1p each

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Nil

22. Total number of shares or debentures over which options held following notification

Mr David Hummel: 189,149

Mr Michael Peacock: 118,355

Mr Tim Cooper: 13,487

23. Any additional information

24. Name of contact and telephone number for queries

Sonya Moore

01253 897 708

Name and signature of duly authorised officer of issuer responsible for making notification

Sonya Moore

Date of notification

17 February 2010

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMMGMZKNDGGZM
Date   Source Headline
4th Jun 20208:54 amRNSAdditional Listing
3rd Jun 20202:52 pmRNSHolding(s) in Company
1st Jun 20202:33 pmRNSBlock listing Interim Review
29th May 202011:58 amRNSTotal Voting Rights
21st May 20203:14 pmRNSHolding(s) in Company
19th May 202010:31 amRNSDirector/PDMR Shareholding
18th May 202010:19 amRNSDirector Declaration
11th May 20207:00 amRNSVictrex plc Interim Results
5th May 20204:13 pmRNSDisclosure of Rights Attached to Equity Shares
5th May 20209:00 amRNSDirector Declaration
30th Apr 202011:39 amRNSTotal Voting Rights
17th Apr 202012:04 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSMarket Update
3rd Apr 20207:00 amRNSDirector Declaration
31st Mar 20209:22 amRNSTotal Voting Rights
24th Mar 20202:00 pmRNSDirectorate Change
17th Mar 20203:32 pmRNSHolding(s) in Company
17th Mar 20202:52 pmRNSDirector/PDMR Shareholding
16th Mar 202010:05 amRNSHolding(s) in Company
12th Mar 202012:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20209:49 amRNSDirector/PDMR Shareholding
28th Feb 202011:56 amRNSTotal Voting Rights
20th Feb 20204:50 pmRNSDirector/PDMR Shareholding
13th Feb 20201:59 pmRNSDirector/PDMR Shareholding
6th Feb 20202:34 pmRNSDirector/PDMR Shareholding
6th Feb 20201:20 pmRNSResult of AGM
6th Feb 202010:54 amRNSDirector/PDMR Shareholding
6th Feb 20207:00 amRNSAGM and Q1 Interim Management Statement
5th Feb 20204:22 pmRNSHolding(s) in Company
4th Feb 20203:42 pmRNSHolding(s) in Company
31st Jan 202010:39 amRNSTotal Voting Rights
20th Jan 202010:04 amRNSDirector/PDMR Shareholding
17th Jan 202010:38 amRNSDirector/PDMR Shareholding
13th Jan 20204:06 pmRNSHolding(s) in Company
13th Jan 20208:46 amRNSJoint Venture
3rd Jan 202012:00 pmRNSAnnual Financial Report
31st Dec 20199:00 amRNSTotal Voting Rights
23rd Dec 20191:44 pmRNSHolding(s) in Company
17th Dec 20192:20 pmRNSDirector/PDMR Shareholding
12th Dec 201910:04 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSPreliminary Results 2019
2nd Dec 20191:52 pmRNSBlock listing Interim Review
29th Nov 201911:38 amRNSTotal Voting Rights
19th Nov 201911:02 amRNSDirector/PDMR Shareholding
12th Nov 201912:00 pmRNSDirectorate Change
31st Oct 201911:36 amRNSTotal Voting Rights
28th Oct 20191:41 pmRNSHolding(s) in Company
18th Oct 20194:01 pmRNSHolding(s) in Company
18th Oct 20192:20 pmRNSDirector/PDMR Shareholding
16th Oct 201911:04 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.